Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leishmania spp. parasite membranes and cellular structures represent the fundamental physical and functional boundaries of the protozoan parasites responsible for leishmaniasis. These structures include the plasma membrane, which is characterized by a high concentration of ergosterol and specialized surface glycoconjugates like lipophosphoglycan (LPG) and GP63 protease, essential for survival within the host macrophage (Source: PMID: 12624100). Internal cellular structures, such as the kinetoplast (a specialized mitochondrial DNA network) and glycosomes, are vital for energy metabolism and parasite replication (Source: PMID: 25634461). The integrity of these membranes is crucial for maintaining osmotic balance and protecting the parasite from the acidic environment of the host's phagolysosome. Many frontline anti-leishmanial therapies exert their effects by compromising the integrity or function of these membranes. For example, Amphotericin B selectively binds to leishmanial ergosterol, forming lethal pores that cause ion leakage and cell lysis (Source: NIH/PubChem). Miltefosine, an oral agent, targets phospholipid metabolism and disrupts membrane-mediated signaling, leading to apoptosis-like death in the parasite (Source: PMID: 22944344).
Disruption of membrane integrity via ergosterol binding, inhibition of phospholipid metabolism, and interference with mitochondrial membrane potential (Source: PMID: 22944344, NIH/PubChem).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leishmania species parasite membranes and cellular structures.